期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 6, 期 7, 页码 782-786出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.5b00118
关键词
Protein tyrosine phosphatase; pTyr mimetics; SHP2 inhibitors; fragment-based library; anticancer agents
资金
- NIH [CA152194, CA69202, CA151765]
- FAMRI (Flight Attendant Medical Research Institute Fund)
- ICTR [UL1 RR 025005]
Protein tyrosine phosphatases (PTPs) are potential therapeutic targets for many diseases. Unfortunately, despite considerable drug discovery efforts devoted to PTPs, obtaining selective and cell permeable PTP inhibitors remains highly challenging. We describe a strategy to explore the existing drug space for previously unknown PTP inhibitory activities. This led to the discovery of cefsulodin as an inhibitor of SHP2, an oncogenic phosphatase in the PTP family. Crystal structure analysis of SHP2 interaction with cefsulodin identified sulfophenyl acetic amide (SPAA) as a novel phosphotyrosine (pTyr) mimetic. A structure-guided and SPAA fragment-based focused library approach produced several potent and selective SHP2 inhibitors. Notably, these inhibitors blocked SHP2-mediated signaling events and proliferation in several cancer cell lines. Thus, SPAA may serve as a new platform for developing chemical probes for other PTPs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据